FOUNTAIN LIFE
Dilution Modeling
Simulate how a new funding round impacts existing ownership
New Round Parameters
$50M
$500M
Post-Money
$550M
Dilution
9.1%
Price/Unit
$27.27
New Units
1,833,362
Current Cap Table
18,333,616 total units · $44.8M capital
Physician Founders19.1%
(FTS) Founding Team42.0%
Series A-1 Preferred8.9%
Post-Series B Cap Table
20,166,977 total units · $94.8M capital
Physician Founders
−-5.7%24.8%
(FTS) Founding Team
−-12.6%54.5%
Series A-1 Preferred
−-2.7%11.6%
Series B (New)9.1%
Dilution Impact Summary
| Share Class | Units | Pre-Round % | Post-Round % | Dilution | Post Value @ Pre-Money |
|---|---|---|---|---|---|
| Physician Founders | 5,000,000 | 19.08% | 24.79% | −-5.71% | $136.4M |
| (FTS) Founding Team | 10,992,478 | 41.96% | 54.51% | −-12.55% | $299.8M |
| Series A-1 Preferred | 2,341,138 | 8.94% | 11.61% | −-2.67% | $63.8M |
| Series B (New) | 1,833,362 | — | 9.09% | — | $50.0M |
| Total | 20,166,977 | 100.00% | 100.00% | $550.0M |
This model assumes a simple equity round with no anti-dilution provisions, no option pool expansion, and no conversion of existing preferred shares. Actual dilution may vary based on negotiated terms, participation rights, and protective provisions in existing shareholder agreements. Consult with legal counsel before making investment decisions.
Confidential — Attorney-Client Privileged · Fountain Life Holdings, LLC